Cas:7338-74-1 6-benzyl-3-methylsulfanyl-2H-1,2,4-triazin-5-one manufacturer & supplier

We serve Chemical Name:6-benzyl-3-methylsulfanyl-2H-1,2,4-triazin-5-one CAS:7338-74-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-benzyl-3-methylsulfanyl-2H-1,2,4-triazin-5-one

Chemical Name:6-benzyl-3-methylsulfanyl-2H-1,2,4-triazin-5-one
CAS.NO:7338-74-1
Synonyms:6-benzyl-3-methylsulfanyl-4H-[1,2,4]triazin-5-one;6-benzyl-3-methylthio[1,2,4]triazin-5(2H)-one;3-Methylthio-5-oxo-6-benzyl-2,5-dihydro-1,2,4-triazin;6-benzyl-3-methylsulphanyl-2H-[1,2,4]triazin-5-one;3-(methylthio)-6-benzyl-1,2,4-triazin-5(2H)-one;6-Benzyl-3-(methylsulfanyl)-1,2,4-triazin-5(2H)-one
Molecular Formula:C11H11N3OS
Molecular Weight:233.29000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:84.20000
Exact Mass:233.06200
LogP:1.88990

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-benzyl-3-methylsulfanyl-4H-[1,2,4]triazin-5-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Benzyl-3-(methylsulfanyl)-1,2,4-triazin-5(2H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-benzyl-3-methylsulfanyl-4H-[1,2,4]triazin-5-one Use and application,3-Methylthio-5-oxo-6-benzyl-2,5-dihydro-1,2,4-triazin technical grade,usp/ep/jp grade.


Related News: The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. 2-(2-chloro-4-iodo-phenylamino)-3,4-difluoro-N-hydroxy-5-(2-morpholin-4-yl-ethylsulfamoyl)-benzamide manufacturers In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 1-(2,2-Dimethyl-propyl)-2,2,2,4,4,4-hexafluoro-3-methyl-2λ5,4λ5-[1,3,2,4]diazadiphosphetidine suppliers “Slower growth in China is no question,” AstraZeneca CEO Pascal Soriot told investors on the call. “We believe we can continue growing [and] maintain our position of leadership, but it’s going to be more difficult moving forward.” (Z)-2-Cyano-3-(2-ethoxy-naphthalen-1-yl)-acrylic acid 2,3-dihydroxy-propyl ester vendor & factory.